We bring you the latest updates from The Regulatory Review through a simple and fast subscription.
We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.
Unsubscribe at any time without hassle.
The Regulatory Review's title: The Regulatory Review
Is this your feed? Claim it!
Prediction markets—which allow participants to buy and sell contracts that may pay out depending on the outcome of predetermined future events—have
By the end of 2025, the U.S. Food and Drug Administration (FDA) had authorized more than 1,450 artificial intelligence-enabled medical devices, and the agency
One of the constant frustrations of the executive branch comes when an administration wants to enact a particular policy but the U.S. Congress—either deliberately or by omission—has not provided sufficient legislative tools to move the ball forward. In these situations, regulators may be able to address only part of a problem. If the Administration wants to take a more aggres...
Unexpectedly, the Biden and second Trump Administrations have together made the case for fundamental antitrust reform in the United States. During the Biden years, the U.S. Department of Justice and Federal Trade Commiss...